- Home
- DARE vs FOXX Comparison
DARE vs FOXX Comparison
Compare DARE & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- FOXX
- Stock Information
- Founded
- DARE 2015
- FOXX 2017
- Country
- DARE United States
- FOXX United States
- Employees
- DARE N/A
- FOXX N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- FOXX
- Sector
- DARE Health Care
- FOXX
- Exchange
- DARE Nasdaq
- FOXX Nasdaq
- Market Cap
- DARE 28.6M
- FOXX 30.5M
- IPO Year
- DARE N/A
- FOXX N/A
- Fundamental
- Price
- DARE $1.91
- FOXX $3.31
- Analyst Decision
- DARE Strong Buy
- FOXX
- Analyst Count
- DARE 2
- FOXX 0
- Target Price
- DARE $10.00
- FOXX N/A
- AVG Volume (30 Days)
- DARE 173.3K
- FOXX 19.2K
- Earning Date
- DARE 11-13-2025
- FOXX 10-24-2025
- Dividend Yield
- DARE N/A
- FOXX N/A
- EPS Growth
- DARE N/A
- FOXX N/A
- EPS
- DARE N/A
- FOXX N/A
- Revenue
- DARE N/A
- FOXX $65,919,166.00
- Revenue This Year
- DARE $5,401.89
- FOXX N/A
- Revenue Next Year
- DARE $6,257.18
- FOXX N/A
- P/E Ratio
- DARE N/A
- FOXX N/A
- Revenue Growth
- DARE N/A
- FOXX 1941.75
- 52 Week Low
- DARE $1.76
- FOXX $2.45
- 52 Week High
- DARE $9.19
- FOXX $11.00
- Technical
- Relative Strength Index (RSI)
- DARE 43.71
- FOXX 30.68
- Support Level
- DARE $1.76
- FOXX $2.93
- Resistance Level
- DARE $1.99
- FOXX $3.71
- Average True Range (ATR)
- DARE 0.10
- FOXX 0.31
- MACD
- DARE -0.01
- FOXX -0.05
- Stochastic Oscillator
- DARE 41.44
- FOXX 28.11
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About FOXX Foxx Development Holdings Inc. Common Stock
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.